News

Transfer to PCI Hospital Slows STEMI Treatment


 

Major Finding: The recommended door-in to door-out time of 30 minutes or less was observed in only 11% of transferred STEMI patients requiring revascularization.

Data Source: Retrospective analysis of 14,821 patients with STEMI transferred to 298 STEMI receiving hospitals for primary PCI.

Disclosures: The American College of Cardiology Foundation's National Cardiovascular Data Registry sponsored the study. The ACTION Registry-GWTG is supported in part by the Bristol-Myers Squibb partnership. Dr. Wang reports receiving research grants from the BMS/Sanofi partnership, Schering Plough/Merck, The Medicines Company, Heartscape, Canyon Pharmaceuticals, and Eli Lilly/Daiichi Sankyo Alliance, as well as consulting fees/honoraria from Medco and Astra Zeneca. Four of her coauthors report financial relationships with several drug firms.

Only 11% of patients with ST-elevation myocardial infarction who presented at a hospital without acute percutaneous coronary intervention capability got in and out of the referral hospital within the recommended benchmark of 30 minutes or less, in a retrospective analysis of 14,821 patients.

Moreover, STEMI patients who had a door-in to door-out (DIDO) time of more than 30 minutes had significantly higher in-hospital mortality of 5.9% compared with 2.7% for patients with a DIDO time of 30 minutes or less (see chart).

This mortality risk remained significant even after adjustment for differences in baseline patient characteristics and presenting features (adjusted odds ratio 1.56), Dr. Tracy Y. Wang and her associates reported (JAMA 2011;305:2540-7).

“DIDO time is a useful performance measure attributable to STEMI referral hospitals that can be used to assess and iteratively improve effectiveness of regional STEMI networks and may further emerge as a quality benchmark to ascertain performance and accountability,” the authors wrote.

They go on to suggest that “further attention and improvement of this performance measure will translate into substantial improvement in the timeliness of primary PCI and clinical outcomes for transferred STEMI patients.”

Hospitals typically focus on shortening overall door-to-balloon (DTB) times as a way to improve the outcomes of STEMI patients, but little has been known about the impact of DIDO times as a component of the interhospital transfer process.

DIDO times are increasingly being advocated as a new quality of care metric for transferred STEMI patients, with a national benchmark of 30 minutes or less recommended by the 2008 American College of Cardiology/American Heart Association performance measures for acute myocardial infarction (J. Am. Coll. Cardiol. 2008;52:2046-99).

Dr. Wang and her associates identified 14,821 STEMI patients transferred to 298 STEMI receiving hospitals for primary PCI in the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry–Get With the Guidelines during January 2007–March 2010. The median DIDO time was 68 minutes (interquartile range 43-120 minutes).

Only 11% (1,627) of patients had a DIDO time of 30 minutes or less, while 56% had a DIDO time greater than 60 minutes, and more than one-third (35%) had a DIDO time greater than 90 minutes, reported Dr. Wang of Duke Clinical Research Institute, Durham, N.C.

Patients with a DIDO time of more than 30 minutes were significantly more likely than were those with shorter DIDO times to be older; to be female; to have comorbidities such as hypertension, diabetes, and prior heart failure or stroke; and to present during off hours.

A left bundle branch block or signs of posterior myocardial infarction on the presenting ECG were also more common in those with prolonged DIDO times.

Notably, only a small minority of patients with a prolonged DIDO time (less than 1%) had contraindications to fibrinolytic therapy, which is the preferred reperfusion strategy for STEMI when access to timely primary PCI is not a viable option, Dr. Wang pointed out.

The percentage of patients achieving the guideline-recommended overall door-to-balloon time of 90 minutes or less was significantly higher for patients with a DIDO time of 30 minutes or less, compared with patients with a DIDO time greater than 30 minutes (60% vs. 13%), she reported. Accordingly, the median DTB times were significantly shorter, at 85 minutes vs. 127 minutes, respectively.

The observed in-hospital mortality rate was 5.5% during the study period. The median length of hospitalization was 3 days among all patients.

Using patients with a DIDO time of 30 minutes or less as the reference, risk-adjusted mortality increased as DIDO times lengthened from a range of 31-60 minutes (OR 1.34) to 61-90 minutes (OR 1.41) and beyond 90 minutes (OR 1.86).

“Our results underscore the importance of optimizing regional and statewide networks for STEMI systems of care,” Dr. Wang wrote.

Most American hospitals lack round-the-clock PCI capacity, although a substantial proportion of contemporary STEMI patients require interhospital transfer for primary PCI. An analysis reported earlier this year by the same group revealed that between 2005 and 2007, fewer than 10% of transferred patients with STEMI met the metric of overall door-to-balloon time of less than 90 minutes (Am. Heart J. 2011;161:76-83, e1).

Pages

Recommended Reading

CABG Track Record Improved in Past Decade
MDedge Cardiology
TEVAR Edges Open Surgical Repair in Smaller U.S. Hospitals
MDedge Cardiology
CABG Outcomes Support More Liberal Blood Glucose Range
MDedge Cardiology
Certain Antibodies Raise Rejection Risk in Heart Transplant Recipients
MDedge Cardiology
Aneurysm Complexity Influences Outcome
MDedge Cardiology
In-Hospital Mortality Risk Increases With DIDO Time for STEMI Patients
MDedge Cardiology
New LVAD May Benefit High-Risk PCI Patients
MDedge Cardiology
Shorter Antiplatelet Tx After Stenting Safe
MDedge Cardiology
DES Boosted Survival in Primary PCI Patients : Higher 5-year survival with drug-eluting stents shows safety in setting of myocardial infarction.
MDedge Cardiology
FDA Expands Carotid Stent Indication to Standard-Risk Patients
MDedge Cardiology